Psychiatry Update 2014

CHICAGO – How does a primary care doctor know when an adolescent patient’s unruliness has crossed the line into pathology? Dr. Jon E. Grant of the University of Chicago presented clinical perspectives about this and other aspects of what he called "disorders of impulsivity" at Psychiatry Update 2014, sponsored by Current Psychiatry and the American Academy of Clinical Psychiatrists.

"This is always the argument: ‘What separates out poorly mannered, poorly behaved people, compared to people with a disorder? ’ " Dr. Grant said in an interview. "It’s a constellation of symptoms, and the intensity and frequency of the symptoms."

Many pediatricians and family physicians might not be aware of how a patient’s predilection for pyromania or kleptomania also could indicate deeper troubles along the impulsivity spectrum. Dr. Grant offered advice on counseling these patients and their families and on when to refer them to a psychiatrist.

Current Psychiatry and this news organization are owned by the same parent company. Dr. Grant disclosed that he has relationships with Forest Pharmaceuticals, Roche, and Lundbeck.

[email protected]

On Twitter @whitneymcknight

CHICAGO – How does a primary care doctor know when an adolescent patient’s unruliness has crossed the line into pathology? Dr. Jon E. Grant of the University of Chicago presented clinical perspectives about this and other aspects of what he called "disorders of impulsivity" at Psychiatry Update 2014, sponsored by Current Psychiatry and the American Academy of Clinical Psychiatrists.

"This is always the argument: ‘What separates out poorly mannered, poorly behaved people, compared to people with a disorder? ’ " Dr. Grant said in an interview. "It’s a constellation of symptoms, and the intensity and frequency of the symptoms."

Many pediatricians and family physicians might not be aware of how a patient’s predilection for pyromania or kleptomania also could indicate deeper troubles along the impulsivity spectrum. Dr. Grant offered advice on counseling these patients and their families and on when to refer them to a psychiatrist.

Current Psychiatry and this news organization are owned by the same parent company. Dr. Grant disclosed that he has relationships with Forest Pharmaceuticals, Roche, and Lundbeck.

[email protected]

On Twitter @whitneymcknight

CHICAGO – How does a primary care doctor know when an adolescent patient’s unruliness has crossed the line into pathology? Dr. Jon E. Grant of the University of Chicago presented clinical perspectives about this and other aspects of what he called "disorders of impulsivity" at Psychiatry Update 2014, sponsored by Current Psychiatry and the American Academy of Clinical Psychiatrists.

"This is always the argument: ‘What separates out poorly mannered, poorly behaved people, compared to people with a disorder? ’ " Dr. Grant said in an interview. "It’s a constellation of symptoms, and the intensity and frequency of the symptoms."

Many pediatricians and family physicians might not be aware of how a patient’s predilection for pyromania or kleptomania also could indicate deeper troubles along the impulsivity spectrum. Dr. Grant offered advice on counseling these patients and their families and on when to refer them to a psychiatrist.

Current Psychiatry and this news organization are owned by the same parent company. Dr. Grant disclosed that he has relationships with Forest Pharmaceuticals, Roche, and Lundbeck.

[email protected]

On Twitter @whitneymcknight

CHICAGO – How does a primary care doctor know when an adolescent patient’s unruliness has crossed the line into pathology? Dr. Jon E. Grant of the University of Chicago presented clinical perspectives about this and other aspects of what he called "disorders of impulsivity" at Psychiatry Update 2014, sponsored by Current Psychiatry and the American Academy of Clinical Psychiatrists.

"This is always the argument: ‘What separates out poorly mannered, poorly behaved people, compared to people with a disorder? ’ " Dr. Grant said in an interview. "It’s a constellation of symptoms, and the intensity and frequency of the symptoms."

Many pediatricians and family physicians might not be aware of how a patient’s predilection for pyromania or kleptomania also could indicate deeper troubles along the impulsivity spectrum. Dr. Grant offered advice on counseling these patients and their families and on when to refer them to a psychiatrist.

Current Psychiatry and this news organization are owned by the same parent company. Dr. Grant disclosed that he has relationships with Forest Pharmaceuticals, Roche, and Lundbeck.

[email protected]

On Twitter @whitneymcknight

CHICAGO – How does a primary care doctor know when an adolescent patient’s unruliness has crossed the line into pathology? Dr. Jon E. Grant of the University of Chicago presented clinical perspectives about this and other aspects of what he called "disorders of impulsivity" at Psychiatry Update 2014, sponsored by Current Psychiatry and the American Academy of Clinical Psychiatrists.

"This is always the argument: ‘What separates out poorly mannered, poorly behaved people, compared to people with a disorder? ’ " Dr. Grant said in an interview. "It’s a constellation of symptoms, and the intensity and frequency of the symptoms."

Many pediatricians and family physicians might not be aware of how a patient’s predilection for pyromania or kleptomania also could indicate deeper troubles along the impulsivity spectrum. Dr. Grant offered advice on counseling these patients and their families and on when to refer them to a psychiatrist.

Current Psychiatry and this news organization are owned by the same parent company. Dr. Grant disclosed that he has relationships with Forest Pharmaceuticals, Roche, and Lundbeck.

[email protected]

On Twitter @whitneymcknight

CHICAGO – How does a primary care doctor know when an adolescent patient’s unruliness has crossed the line into pathology? Dr. Jon E. Grant of the University of Chicago presented clinical perspectives about this and other aspects of what he called "disorders of impulsivity" at Psychiatry Update 2014, sponsored by Current Psychiatry and the American Academy of Clinical Psychiatrists.

"This is always the argument: ‘What separates out poorly mannered, poorly behaved people, compared to people with a disorder? ’ " Dr. Grant said in an interview. "It’s a constellation of symptoms, and the intensity and frequency of the symptoms."

Many pediatricians and family physicians might not be aware of how a patient’s predilection for pyromania or kleptomania also could indicate deeper troubles along the impulsivity spectrum. Dr. Grant offered advice on counseling these patients and their families and on when to refer them to a psychiatrist.

Current Psychiatry and this news organization are owned by the same parent company. Dr. Grant disclosed that he has relationships with Forest Pharmaceuticals, Roche, and Lundbeck.

[email protected]

On Twitter @whitneymcknight

CHICAGO – "We’re often not very well educated in medical school or in our residencies about how to talk to patients about sexual functioning and dysfunction," according to Dr. Anita H. Clayton, the interim chair of psychiatry and neurobehavioral sciences, and David C. Wilson Professor of Psychiatry at the University of Virginia, Charlottesville.

"Very often we feel we don’t have time to talk about it [with patients]," Dr. Clayton adds in this video recorded during the 2014 Psychiatry Update sponsored by Current Psychiatry and the American Academy of Clinical Psychiatrists, where Dr. Clayton was a presenter.

Patients might schedule an appointment with a doctor to talk about one thing, but what they really hope to discuss is their sexual dysfunction, despite not quite knowing how to go about it. When a provider can overcome his or her own embarrassment about the topic, "Patients often open up very easily, and they really do want to talk," says Dr. Clayton, also professor of clinical obstetrics and gynecology at the university.

Hear how Dr. Clayton suggests providers approach the sensitive topic of sexual dysfunction to help their patients return to having a healthy sex life.

Current Psychiatry and this news organization are owned by the same parent company.

[email protected]

On Twitter @whitneymcknight

CHICAGO – "We’re often not very well educated in medical school or in our residencies about how to talk to patients about sexual functioning and dysfunction," according to Dr. Anita H. Clayton, the interim chair of psychiatry and neurobehavioral sciences, and David C. Wilson Professor of Psychiatry at the University of Virginia, Charlottesville.

"Very often we feel we don’t have time to talk about it [with patients]," Dr. Clayton adds in this video recorded during the 2014 Psychiatry Update sponsored by Current Psychiatry and the American Academy of Clinical Psychiatrists, where Dr. Clayton was a presenter.

Patients might schedule an appointment with a doctor to talk about one thing, but what they really hope to discuss is their sexual dysfunction, despite not quite knowing how to go about it. When a provider can overcome his or her own embarrassment about the topic, "Patients often open up very easily, and they really do want to talk," says Dr. Clayton, also professor of clinical obstetrics and gynecology at the university.

Hear how Dr. Clayton suggests providers approach the sensitive topic of sexual dysfunction to help their patients return to having a healthy sex life.

Current Psychiatry and this news organization are owned by the same parent company.

[email protected]

On Twitter @whitneymcknight

CHICAGO – "We’re often not very well educated in medical school or in our residencies about how to talk to patients about sexual functioning and dysfunction," according to Dr. Anita H. Clayton, the interim chair of psychiatry and neurobehavioral sciences, and David C. Wilson Professor of Psychiatry at the University of Virginia, Charlottesville.

"Very often we feel we don’t have time to talk about it [with patients]," Dr. Clayton adds in this video recorded during the 2014 Psychiatry Update sponsored by Current Psychiatry and the American Academy of Clinical Psychiatrists, where Dr. Clayton was a presenter.

Patients might schedule an appointment with a doctor to talk about one thing, but what they really hope to discuss is their sexual dysfunction, despite not quite knowing how to go about it. When a provider can overcome his or her own embarrassment about the topic, "Patients often open up very easily, and they really do want to talk," says Dr. Clayton, also professor of clinical obstetrics and gynecology at the university.

Hear how Dr. Clayton suggests providers approach the sensitive topic of sexual dysfunction to help their patients return to having a healthy sex life.

Current Psychiatry and this news organization are owned by the same parent company.

[email protected]

On Twitter @whitneymcknight

CHICAGO – "Having insomnia increases the risk of suicidality," according to Thomas Roth, Ph.D., a speaker at this year’s Psychiatry Update 2014 sponsored by Current Psychiatry and the American Academy of Clinical Psychiatrists. "This is especially true in adolescents."

In this video, Dr. Roth of Henry Ford Hospital in Detroit discusses what primary care physicians can do to help manage the drastic impact insomnia can have on a person’s life, and he explores the relationship sleeplessness has with suicide and depression. He also discusses how insomnia can be triggered by a variety of medications, including beta-blockers.

Current Psychiatry and this news organization are owned by the same parent company.

[email protected]

On Twitter @whitneymcknight

CHICAGO – "Having insomnia increases the risk of suicidality," according to Thomas Roth, Ph.D., a speaker at this year’s Psychiatry Update 2014 sponsored by Current Psychiatry and the American Academy of Clinical Psychiatrists. "This is especially true in adolescents."

In this video, Dr. Roth of Henry Ford Hospital in Detroit discusses what primary care physicians can do to help manage the drastic impact insomnia can have on a person’s life, and he explores the relationship sleeplessness has with suicide and depression. He also discusses how insomnia can be triggered by a variety of medications, including beta-blockers.

Current Psychiatry and this news organization are owned by the same parent company.

[email protected]

On Twitter @whitneymcknight

CHICAGO – "Having insomnia increases the risk of suicidality," according to Thomas Roth, Ph.D., a speaker at this year’s Psychiatry Update 2014 sponsored by Current Psychiatry and the American Academy of Clinical Psychiatrists. "This is especially true in adolescents."

In this video, Dr. Roth of Henry Ford Hospital in Detroit discusses what primary care physicians can do to help manage the drastic impact insomnia can have on a person’s life, and he explores the relationship sleeplessness has with suicide and depression. He also discusses how insomnia can be triggered by a variety of medications, including beta-blockers.

Current Psychiatry and this news organization are owned by the same parent company.

[email protected]

On Twitter @whitneymcknight

CHICAGO – The Food and Drug Administration’s letter rating scale is "unreliable" when it comes to prescribing antidepressants for pregnant women, according to Dr. Marlene P. Freeman, director of clinical services for the perinatal and reproductive psychiatry clinical research program at Massachusetts General Hospital in Boston.

"It’s actually very important to disregard those letters and turn to actual data when making clinical decisions, which can be very difficult for the individual practitioner who doesn’t specialize in this area," Dr. Freeman said in an interview during Psychiatry Update 2014, sponsored by Current Psychiatry and the American Academy of Clinical Psychiatrists.

Other concerns Dr. Freeman thinks clinicians treating pregnant women with depression need to be aware of include which SSRIs can lead to cardiovascular malformations in the child, as well as which ones have been associated with spontaneous abortions. Dr. Freeman also discusses what supplementation offers promise for preventing autism, and when omega-3 fatty acid supplementation is appropriate for first-line therapy in depression.

Current Psychiatry and this news organization are owned by the same parent company.

[email protected]

On Twitter @whitneymcknight

CHICAGO – The Food and Drug Administration’s letter rating scale is "unreliable" when it comes to prescribing antidepressants for pregnant women, according to Dr. Marlene P. Freeman, director of clinical services for the perinatal and reproductive psychiatry clinical research program at Massachusetts General Hospital in Boston.

"It’s actually very important to disregard those letters and turn to actual data when making clinical decisions, which can be very difficult for the individual practitioner who doesn’t specialize in this area," Dr. Freeman said in an interview during Psychiatry Update 2014, sponsored by Current Psychiatry and the American Academy of Clinical Psychiatrists.

Other concerns Dr. Freeman thinks clinicians treating pregnant women with depression need to be aware of include which SSRIs can lead to cardiovascular malformations in the child, as well as which ones have been associated with spontaneous abortions. Dr. Freeman also discusses what supplementation offers promise for preventing autism, and when omega-3 fatty acid supplementation is appropriate for first-line therapy in depression.

Current Psychiatry and this news organization are owned by the same parent company.

[email protected]

On Twitter @whitneymcknight

CHICAGO – The Food and Drug Administration’s letter rating scale is "unreliable" when it comes to prescribing antidepressants for pregnant women, according to Dr. Marlene P. Freeman, director of clinical services for the perinatal and reproductive psychiatry clinical research program at Massachusetts General Hospital in Boston.

"It’s actually very important to disregard those letters and turn to actual data when making clinical decisions, which can be very difficult for the individual practitioner who doesn’t specialize in this area," Dr. Freeman said in an interview during Psychiatry Update 2014, sponsored by Current Psychiatry and the American Academy of Clinical Psychiatrists.

Other concerns Dr. Freeman thinks clinicians treating pregnant women with depression need to be aware of include which SSRIs can lead to cardiovascular malformations in the child, as well as which ones have been associated with spontaneous abortions. Dr. Freeman also discusses what supplementation offers promise for preventing autism, and when omega-3 fatty acid supplementation is appropriate for first-line therapy in depression.

Current Psychiatry and this news organization are owned by the same parent company.

[email protected]

On Twitter @whitneymcknight

CHICAGO – Research continues into whether the anesthetic ketamine will deliver on what some see as its potential to be a notably effective treatment for refractory depression, but other medical treatments are also under review.

Dr. James Jefferson scanned the depression treatment horizon in a presentation at Psychiatry Update 2014, sponsored by Current Psychiatry and the American Academy of Clinical Psychiatrists. In a video interview, Dr. Jefferson of the University of Wisconsin, Madison, forecasts what he thinks will – or won’t – enter the armamentarium. Might that include Botox? And how promising is the nutritional supplement SAMe?

Dr. Jefferson shares his thoughts on these and other contenders, and he considers when atypical antipsychotics are appropriate for treating depression. He also delivers stern words to clinicians who do not read the package inserts in the medications they prescribe.

Current Psychiatry and this news organization are owned by the same parent company.

[email protected]

On Twitter @whitneymcknight

CHICAGO – Research continues into whether the anesthetic ketamine will deliver on what some see as its potential to be a notably effective treatment for refractory depression, but other medical treatments are also under review.

Dr. James Jefferson scanned the depression treatment horizon in a presentation at Psychiatry Update 2014, sponsored by Current Psychiatry and the American Academy of Clinical Psychiatrists. In a video interview, Dr. Jefferson of the University of Wisconsin, Madison, forecasts what he thinks will – or won’t – enter the armamentarium. Might that include Botox? And how promising is the nutritional supplement SAMe?

Dr. Jefferson shares his thoughts on these and other contenders, and he considers when atypical antipsychotics are appropriate for treating depression. He also delivers stern words to clinicians who do not read the package inserts in the medications they prescribe.

Current Psychiatry and this news organization are owned by the same parent company.

[email protected]

On Twitter @whitneymcknight

CHICAGO – Research continues into whether the anesthetic ketamine will deliver on what some see as its potential to be a notably effective treatment for refractory depression, but other medical treatments are also under review.

Dr. James Jefferson scanned the depression treatment horizon in a presentation at Psychiatry Update 2014, sponsored by Current Psychiatry and the American Academy of Clinical Psychiatrists. In a video interview, Dr. Jefferson of the University of Wisconsin, Madison, forecasts what he thinks will – or won’t – enter the armamentarium. Might that include Botox? And how promising is the nutritional supplement SAMe?

Dr. Jefferson shares his thoughts on these and other contenders, and he considers when atypical antipsychotics are appropriate for treating depression. He also delivers stern words to clinicians who do not read the package inserts in the medications they prescribe.

Current Psychiatry and this news organization are owned by the same parent company.

[email protected]

On Twitter @whitneymcknight